HemaCare Co. (OTCMKTS:HEMA – Get Free Report) shares traded up 0.6% during mid-day trading on Thursday . The company traded as high as $25.31 and last traded at $25.31. 5,400 shares changed hands during trading, a decline of 86% from the average session volume of 39,950 shares. The stock had previously closed at $25.16.
HemaCare Trading Up 0.6 %
The stock has a fifty day moving average of $25.31 and a 200-day moving average of $25.31.
HemaCare Company Profile
HemaCare Corporation provides human-derived primary blood cells and tissues for biomedical research, and supporting cell therapy clinical trials and commercialization with apheresis collections in the United States. The company specializes in the customized collection, isolation, and testing of primary human blood cells and other biological products for research protocols and cellular therapy.
Recommended Stories
- Five stocks we like better than HemaCare
- 3 Warren Buffett Stocks to Buy Now
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- Trading Halts Explained
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Receive News & Ratings for HemaCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HemaCare and related companies with MarketBeat.com's FREE daily email newsletter.
